Abbott ID Now Study Data Confirms Test Sensitivity and Specificity

Oct 07, 2020

|

NEW YORK – Abbott Laboratories released data from an interim clinical study on Wednesday that confirmed the sensitivity and specificity of its ID Now COVID-19 rapid test.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon
Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing
FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit
LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test
Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs
In Brief This Week: PerkinElmer, Rady Children's Institute for Genomic Medicine, Myriad Genetics, and More

The Scan

CMS Letter to Orig3n

Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.

And After the Test

In an editorial at BMJ Opinion, two genetic counselors call for an increased focus on post-test patient care.

Faster, But Not Fast Enough

A new survey finds people in the US are getting their COVID-19 test results back faster, but not fast enough to help some viral control measures, NPR reports.

PLOS Papers on Plasmodium vivax Variation in Ethiopia, Childhood BMI Loci, More

In PLOS this week: genomic analysis of malaria parasites in Ethiopia, loci linked to childhood BMI, and more.

Featured White Papers

Improving POC Device Manufacturability – 5 Expert Approaches

Best Practices for Point of Care (POC) Product Development

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Nov

10

Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

Menu

Abbott ID Now Study Data Confirms Test Sensitivity and Specificity

To read the full story....

Breaking News

CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon

Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing

FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test

Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

In Brief This Week: PerkinElmer, Rady Children's Institute for Genomic Medicine, Myriad Genetics, and More

The Scan

CMS Letter to Orig3n

And After the Test

Faster, But Not Fast Enough

PLOS Papers on Plasmodium vivax Variation in Ethiopia, Childhood BMI Loci, More

Featured White Papers

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

What's Popular?

Scanogen Developing Direct-From-Blood Infection Test That Could Provide Results in 90 Minutes

Cue Health Receives $481M From DoD to Expand COVID-19 Testing Capacity

Sponsorships